ResMed Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ResMed Inc. with three other
companies in this sector in UNITED STATES :
sales of $988.48 million
of which 47%
Cantel Medical Corp.
of which 46%
was Medical), and
of which 96%
was Impella product revenue).
ResMed Inc. reported sales of $2.96 billion
June of 2020.
increase of 13.4%
versus 2019, when the company's sales were $2.61 billion.
Sales at ResMed Inc. have increased during each of the previous five years
(and since 2015, sales have increased a total of 76%).
Sales of Software As A Service saw an increase
that was more than double the company's growth rate: sales were up
28.6% in 2020, from
$275.80 million to $354.63 million.